OPC Stock Overview
Engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicines in Vietnam and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
OPC Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫23,000.00 |
| 52 Week High | ₫27,000.00 |
| 52 Week Low | ₫22,150.00 |
| Beta | 0.17 |
| 11 Month Change | -1.29% |
| 3 Month Change | -3.97% |
| 1 Year Change | 0% |
| 33 Year Change | -2.75% |
| 5 Year Change | 19.20% |
| Change since IPO | 118.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| OPC | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -0.4% | -0.06% | 0.1% |
| 1Y | 0% | 20.7% | 14.7% |
Return vs Industry: OPC underperformed the VN Pharmaceuticals industry which returned 20.7% over the past year.
Return vs Market: OPC underperformed the VN Market which returned 14.7% over the past year.
Price Volatility
| OPC volatility | |
|---|---|
| OPC Average Weekly Movement | 3.1% |
| Pharmaceuticals Industry Average Movement | 3.2% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in VN Market | 6.8% |
| 10% least volatile stocks in VN Market | 2.2% |
Stable Share Price: OPC has not had significant price volatility in the past 3 months compared to the VN market.
Volatility Over Time: OPC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | 903 | Huong Thi Pham | www.opcpharma.com |
OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicines in Vietnam and internationally. Its primary products include cardiovascular, nerve, nutrition, vitamins and minerals, respiratory system, urinary, musculoskeletal system, external use, digestion, endocrine, pain relief-inflammation, and others. The company also produces and trades in pharmaceutical products, materials, machinery, medical equipment, chemicals, cosmetics, functional foods, anti-malarial products, and food products; and alcoholic beverages, spirits, carbonated drinks, mineral water, and other beverages.
OPC Pharmaceutical Joint Stock Company Fundamentals Summary
| OPC fundamental statistics | |
|---|---|
| Market cap | ₫1.47t |
| Earnings (TTM) | ₫86.16b |
| Revenue (TTM) | ₫951.23b |
17.1x
P/E Ratio1.5x
P/S RatioIs OPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPC income statement (TTM) | |
|---|---|
| Revenue | ₫951.23b |
| Cost of Revenue | ₫498.00b |
| Gross Profit | ₫453.23b |
| Other Expenses | ₫367.07b |
| Earnings | ₫86.16b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.35k |
| Gross Margin | 47.65% |
| Net Profit Margin | 9.06% |
| Debt/Equity Ratio | 0% |
How did OPC perform over the long term?
See historical performance and comparison